Speaking Engagements
Translating complex health law into actionable insights for your audience
Expert Speaker • Trusted Authority
Trident Health Law’s founder brings a unique dual perspective to the podium—combining rigorous legal analysis with practical public health expertise to deliver presentations that resonate with diverse audiences.
Whether addressing seasoned attorneys, healthcare executives, policy makers, or academic audiences, our presentations transform complex regulatory landscapes into clear, actionable insights that drive meaningful discussion and strategic decision-making.
Signature Speaking Topics
The Future of Health Law: AI, Data & Digital Innovation
Navigating the regulatory challenges of artificial intelligence in healthcare, digital therapeutics, and emerging technologies
Public Health Emergency Legal Frameworks
Legal foundations of emergency preparedness, response authorities, and balancing public health with individual rights
HIPAA Evolution: Privacy in the Digital Health Era
Modern privacy challenges, interoperability requirements, and compliance strategies for connected healthcare
Rare Disease Law & Regulatory Science
Legal pathways for rare disease treatments, FDA programs, and advocacy strategies
Healthcare Federalism & Policy Implementation
Navigating federal-state jurisdictional complexities in health policy and regulatory enforcement
Bioethics & Legal Innovation
Legal and ethical considerations in advancing biomedical research and emerging therapeutic modalities
Presentation Formats
Keynote Addresses
Featured presentations
Panel Discussions
Expert moderation
Academic Lectures
University settings
Virtual Events
Webinars & podcasts
Policy Roundtables & Think Tank Briefings
Strategic policy discussions and expert briefings
Request a Speaker
Available for in-person events nationwide and virtual presentations globally
Ready to deliver impactful insights for your next event
Speaker Credentials
Speaking Style
- • Accessible to diverse audiences
- • Evidence-based insights
- • Interactive Q&A sessions
- • Tailored content delivery
Speaking Portfolio
American Health Law Association Fundamentals Conference
“The Fundamentals of Public Health Law” – Chicago, IL (November 2022)
Comprehensive overview of public health legal frameworks for healthcare attorneys
NACCHO360 Conference
“Stigma and Policy: Federal Policies Impacting Substance Use Disorder Perceptions” – Atlanta, GA (July 2022)
Analysis of federal policy impacts on stigma reduction in substance use treatment
International Society of Political Psychology Annual Meeting
“Globalization and the Need for Stronger Global Public Health Laws” – Athens, Greece (July 2022)
International perspective on public health legal frameworks and global governance
Drug Information Association Global Annual Meeting
“A New Way to Determine Value: Leveraging Public Health to Better Identify Value-Based Interventions” – Chicago, IL (June 2022)
Innovative approaches to healthcare value assessment through public health principles
National Organization for Rare Disorders Breakthrough Summit
“Rare Diseases as a Public Health Challenge” – Virtual Plenary (October 2021)
Keynote presentation on legal and policy frameworks for rare disease advocacy
American Public Health Association Annual Meeting
“The Public Health Reserve: An Independent and Decentralized Public Health System” – Virtual (October 2021)
Innovative model for strengthening public health infrastructure and emergency response
National Rural Health Association Annual Conference
“COVID-19 Telehealth Laws and Rural Rare Disease Care” – Virtual (May 2021)
Intersection of telehealth regulatory changes and rural healthcare access for rare diseases
American Health Law Association Long-Term Care Conference
“The Reckoning: Long-Term Care Facility Compliance and Enforcement Post-Pandemic” – Virtual (March 2021)
Analysis of regulatory changes and enforcement trends in long-term care following COVID-19
U.S. Food and Drug Administration Rare Disease Day Meeting
Invited Public Comment – Office of Orphan Products Development (March 2021)
Expert commentary on FDA rare disease programs and regulatory pathways
Legislative Testimony
Maryland General Assembly Joint Committee on Behavioral Health & Opioid Use Disorders
Invited presentation and testimony on behavioral health policy and opioid use disorder treatment frameworks (July 2017)